Patent · US Active

Compounds and methods for kinase modulation, and indications therefor

US12076322B2 · kind B2 · utility

0Cited by

180References

7Claims

0Family size

Assignee

Plexxikon Inc. · US

Inventors

Prabha N. Ibrahim · Mountain View, US
Chao Zhang · 安丰镇, CN
Wayne Spevak · Berkeley, US
Jiazhong Zhang · Foster City, US
Guoxian Wu · Palo Alto, US
Jack Lin · Hercules, US
Hanna Cho · Oakland, US
Marika Nespi · Berkeley, US
Songyuan Shi · Fremont, US
Todd Ewing · San Diego, US
Ying Zhang · Beijing, CN

Key dates

Filing date	Aug 25, 2022
Grant date	Sep 3, 2024
Priority date	—
Expiry date	Aug 25, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds active on protein kinases are described, as well as methods of making and using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.